IonQ (NYSE:IONQ) Shares Up 7.4% - Still a Buy?

Key Points

• IonQ shares rose 7.4% to about $33.04 after the Air Force Research Laboratory awarded the company $7.5 million for the next phase of its quantum-networking program.
• Analysts remain generally positive, with a consensus “Moderate Buy” rating and a $63.33 price target, while upcoming earnings will provide an important test of revenue growth, bookings and guidance.
• Significant risks remain: IonQ is unprofitable, trades at a high valuation, faces competition from larger players such as Alphabet and IBM, and potential dilution from its planned acquisition and $2 billion share sale could pressure shareholders.

IonQ, Inc. (NYSE:IONQ - Get Free Report) traded up 7.4% during trading on Tuesday. The stock traded as high as $33.31 and last traded at $33.0410. 21,909,112 shares changed hands during mid-day trading, a decline of 11% from the average session volume of 24,572,268 shares. The stock had previously closed at $30.76.

Key IonQ News

Here are the key news stories impacting IonQ this week:

• Positive Sentiment: AFRL awards IonQ $7.5 million: The Air Force Research Laboratory provided follow-on funding for Phase 2 of IonQ’s quantum-networking program. The project expands a network previously delivered in Rome, New York, and will develop interoperable optical, hardware and software systems—strengthening IonQ’s government relationships and commercial positioning. IonQ Awarded $7.5 Million Follow-On Funding from AFRL to Advance Full-Stack Quantum Networking
• Positive Sentiment: Analysts remain broadly optimistic: IonQ’s average brokerage recommendation is equivalent to a Buy, and several articles identify the company as a high-growth, pure-play quantum-computing opportunity. However, the bullish view depends on substantial future industry growth and execution. Wall Street Analysts Think IonQ Is a Good Investment: Is It?
• Neutral Sentiment: Earnings are the next major catalyst: Investors are approaching IonQ’s earnings report with contrasting expectations for pure-play quantum companies. IonQ’s prior quarter showed sharply higher revenue and a smaller-than-expected loss, but the company remains unprofitable, making bookings, revenue growth and guidance especially important.
• Negative Sentiment: Valuation remains a significant risk: Despite explosive revenue growth, IonQ trades on expectations of continued expansion rather than current profits. The stock has also faced pressure after the planned Elisity acquisition—valued at up to $1.3 billion in stock—and a $2 billion share sale, which could dilute existing shareholders. IonQ Just Dropped 24% in a Month
• Negative Sentiment: Competitive and market risks persist: Alphabet and IBM have greater infrastructure and funding resources, while Google’s quantum advances could intensify competition. IonQ’s negative earnings and high share-price volatility also leave it vulnerable to profit-taking if growth or acquisition benefits disappoint. Approaching Earnings Season, Are Pure Play Quantum Stocks Still a Good Bet?

Analyst Ratings Changes

IONQ has been the topic of several research analyst reports. Wall Street Zen cut shares of IonQ from a "sell" rating to a "strong sell" rating in a research note on Saturday, August 8th. Wedbush reissued an "outperform" rating and set a $75.00 price objective on shares of IonQ in a report on Tuesday, October 13th. Cantor Fitzgerald restated an "overweight" rating and set a $70.00 price objective on shares of IonQ in a research report on Wednesday, September 9th. Mizuho dropped their target price on shares of IonQ from $61.00 to $52.00 and set an "outperform" rating on the stock in a report on Wednesday, September 9th. Finally, Needham & Company LLC reaffirmed a "buy" rating and issued a $65.00 target price on shares of IonQ in a research report on Wednesday, September 9th. Ten investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $63.33.

IonQ Trading Up 7.4%

The stock has a 50 day simple moving average of $39.49 and a 200-day simple moving average of $42.55. The firm has a market capitalization of $14.19 billion, a P/E ratio of -7.09 and a beta of 3.36.

IonQ (NYSE:IONQ - Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported ($0.33) earnings per share for the quarter, topping the consensus estimate of ($0.56) by $0.23. The firm had revenue of $80.05 million for the quarter, compared to analysts' expectations of $66.47 million. IonQ had a negative net margin of 553.27% and a negative return on equity of 22.29%. The business's quarterly revenue was up 286.7% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.70) EPS. As a group, sell-side analysts expect that IonQ, Inc. will post -2.96 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other IonQ news, insider John Raymond sold 2,407 shares of the business's stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $37.21, for a total transaction of $89,564.47. Following the completion of the sale, the insider owned 77,741 shares of the company's stock, valued at approximately $2,892,742.61. The trade was a 3.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.55% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in IONQ. BlackRock Inc. purchased a new stake in IonQ in the 2nd quarter worth approximately $1,112,945,000. Bank of America Corp DE purchased a new position in IonQ during the second quarter valued at approximately $344,757,000. Bank of New York Mellon Corp bought a new position in shares of IonQ in the second quarter worth approximately $113,863,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of IonQ by 45.0% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,632,290 shares of the company's stock worth $86,936,000 after purchasing an additional 506,191 shares during the period. Finally, Legal & General Group Plc purchased a new stake in shares of IonQ in the second quarter worth $82,126,000. Institutional investors own 41.42% of the company's stock.

About IonQ

IonQ, Inc NYSE: IONQ is a quantum computing company that develops full-stack quantum computing systems and related software. Its technology is based on trapped-ion quantum computing, which uses electrically charged atoms as qubits and is designed to support highly accurate quantum operations.

The company provides access to its quantum computers through cloud platforms and direct enterprise and research engagements. Its offerings include quantum computing hardware, cloud-based access, software tools, and professional services intended to help organizations explore applications in areas such as optimization, chemistry, materials science, artificial intelligence, and cybersecurity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.